ELAB - Company ID 0001840563
The table below shows Elevai Labs Inc.'s balance sheet line items across its last 3 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Cash & equivalents | - | $3.98M | - |
| Short-term investments | $572.05K | - | - |
| Receivables | - | - | - |
| Inventory | $95.10K | - | $495.67K |
| Total current assets | $6.87M | $6.05M | $4.92M |
| Property, plant & equipment | $885.52K | $1.09K | $53.12K |
| Goodwill | $977.77K | - | - |
| Total assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $12.87M |
| $8.99M |
| $5.19M |
| Accounts payable | - | - | - |
| Total current liabilities | $3.94M | $1.80M | $1.30M |
| Long-term debt | - | - | - |
| Total liabilities | $5.03M | $2.33M | $1.36M |
| Retained earnings | -$21.02M | -$13.27M | -$7.02M |
| Total equity | $7.84M | $6.66M | $3.83M |